abstract |
The present invention relates to novel hydroxyethylamine compounds having Asp2, ° -secretase, BACE1, or Memapsin inhibitory activity; procedures for its preparation; compositions that contain them; and its use in the treatment of diseases characterized by elevated concentration of ° -amiloid or deposits of ° -amiloid, particularly Alzheimer's disease. |